Last edition
News about "Vedana Therapeutics"
Vedana Therapeutics Launches with USD 46 Million Series A Financing for Migraine Therapies
Vedana Therapeutics has launched with USD 46 million in Series A financing to advance next-generation migraine therapies. Backed by migraine experts and investors, the company is developing innovative treatments targeting clinically validated pathways to help patients achieve lasting freedom from migraine.
Vedana Therapeutics | 17/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members